Skip to main content

Two routes for tyrosol production by metabolic engineering of Corynebacterium glutamicum

Abstract

Background

The phenolic compound tyrosol is widely used in the pharmaceutical industry, owing to its beneficial effects on human health and its use as a precursor for key pharmaceuticals, including β1-receptor blockers. Tyrosol can be found in olive oil, but despite its natural biosynthesis in plants, low extraction efficiencies render microbial production a more viable alternative.

Results

Here, we engineered the l-tyrosine overproducing Corynebacterium glutamicum strain AROM3 for the de novo production of tyrosol. Two routes were established and compared: one via 4-OH-phenylpyruvate as intermediate and the other via tyramine. We initially expected the first route to require heterologous expression of a prephenate dehydrogenase gene, given that C. glutamicum lacks this enzymatic function. However, heterologous expression of ARO10 from Saccharomyces cerevisiae (ARO10Sc), which encodes a phenylpyruvate decarboxylase, was sufficient to establish tyrosol production in strain AROM3. We identified that 4-OH-phenylpyruvate is synthesized from l-tyrosine by native aminotransferases, which is subsequently decarboxylated by Aro10Sc, and reduced to tyrosol by native alcohol dehydrogenases, leading to a titer of 9.4 ± 1.1 mM (1.30 ± 0.15 g/L). We identified the furfural dehydrogenase FudC as major enzyme involved in this pathway, as its gene deletion reduced tyrosol production by 75%. Given the instability of 4-OH-phenylpyruvate, the synthesis of tyrosol via the stable intermediate tyramine was pursued via the second route. Decarboxylation of l-tyrosine followed by oxidative deamination was accomplished by overexpression of the l-tyrosine decarboxylase gene tdc from Levilactobacillus brevis (tdcLb) and the tyramine oxidase gene tyo from Kocuria rhizophila (tyoKr). Using this route, tyrosol production was increased by 44% compared to the route via 4-OH-phenylpyruvate. With a division of labor approach by co-cultivating l-tyrosine producing strains that either express tdcLb or tyoKr, the highest titer of 14.1 ± 0.3 mM (1.95 ± 0.04 g/L) was achieved.

Conclusions

This study demonstrates the potential of endotoxin-free C. glutamicum as production host for the l-tyrosine-derived product tyrosol. Due to its l-arogenate pathway for l-tyrosine synthesis, the unstable 4-OH-phenylpyruvate could be excluded as intermediate in the Tdc–Tyo pathway, outcompeting the most often utilized production route via phenylpyruvate decarboxylases.

Introduction

Oxidative damage plays a significant role in the development of various diseases, including Alzheimer's, Parkinson's, cardiovascular diseases, and cancer [1]. The phenolic compound tyrosol (2-[4-hydroxyphenyl]-ethanol) can protect tissues and cells from oxidative stress due to regulatory effects [2, 3]. Several studies demonstrated the beneficial impact of the bioactive compound tyrosol on human health, including reducing the risk of cardiovascular or Alzheimer's diseases [4,5,6]. In addition, tyrosol serves as a precursor for commercially available pharmaceutical agents and, thus, finds extensive use in the pharmaceutical industry. Tyrosol is, for example, employed in the synthesis of β1-receptor blockers [7, 8] and salidroside [9], both used to treat cardiovascular diseases [10, 11].

While different chemical synthesis methods are available for the production of tyrosol, e.g., from 4-bromophenol or 2-phenylethanol [12], their main drawbacks are expensive precursors and harsh process conditions. Natural sources of tyrosol such as olive oil offer an alternative supply. Extraction from olives or from olive oil mill wastewater, a byproduct of olive oil production [13], shows low profitability due to low concentrations of tyrosol in plant sources (e.g., 43–68 mg/kg in olive oil [14]), that require complex extraction procedures. Due to the drawbacks of existing processes, there is a growing focus on low-cost and eco-friendly biosynthesis using microorganisms.

Tyrosol can be produced via different routes, which are related to the l-tyrosine synthesis pathway. For one, l-tyrosine itself can be used in biotransformation as a precursor for tyrosol synthesis, which can be decarboxylated to tyramine by an l-tyrosine decarboxylase (Tdc) and subsequently deaminated by a tyramine oxidase (Tyo). The resulting 4-OH-phenylacetaldyhyde can finally be reduced to tyrosol by an alcohol dehydrogenase (Adh) [15]. The immediate precursor 4-OH-phenylacetaldyhyde can, however, also be synthesized by decarboxylation of 4-OH-phenylpyruvate, which is a precursor of l-tyrosine in many microorganisms or can be derived from l-tyrosine as degradation product [16].

Yeasts, such as Saccharomyces cerevisiae and Candida albicans, naturally produce tyrosol as a quorum sensing molecule via the latter pathway [17, 18]. Consequently, they are already equipped with the required enzymatic pathway and have been further engineered to improve the production of tyrosol, resulting in titers up to 1 g/L (7 mM) [19,20,21]. As bacteria, such as Escherichia coli, generally have a higher specific productivity, resulting in lower process costs [22], their genetic engineering for tyrosol production has received considerable attention. E. coli ΔfeaB strains with plasmid-based expression of the phenylpyruvate decarboxylase gene ARO10Sc or expression of tdc and tyo, from Papaver somniferum and Micrococcus luteus, produced 0.41 mM and 0.5 mM tyrosol, respectively [15, 23]. With further metabolic engineering, titers were increased to 4–9 mM tyrosol in shake flask cultivations [23,24,25]. Besides the pathway using Aro10Sc or Tdc and Tyo, other more complex routes have been tried including 5 enzymatically catalyzed steps from l-tyrosine to tyrosol, albeit titers were comparably low [26]. A major challenge in large-scale production, however, is the removal of E. coli lipopolysaccharides, also referred to as endotoxin, which are part of the outer membrane of E. coli. This potent immunostimulant induces a pyrogenic response in humans, leading to symptoms of inflammation, ranging from fever up to septic shock [27].

Endotoxin-free Corynebacterium glutamicum offers several advantages, most notably its established use for industrial production of generally recognized as safe (GRAS) food ingredients, including amino acid production at the million-ton scale [28]. Its previous engineering for l-tyrosine overproduction makes C. glutamicum a superior candidate for producing the l-tyrosine derivative tyrosol. Overproduction of l-tyrosine was achieved by metabolic engineering, which included the genomic integration of the gene encoding a feedback-inhibition-resistant mutant of the 3-deoxy-d-arabinoheptulosonate-7-phosphate (DAHP) synthase from E. coli (aroGEcfbr). In addition, start codon exchanges from ATG to the less frequently used TTG in the genes pheA and trpE were introduced to reduce the competing biosynthesis of the amino acids l-phenylalanine and l-tryptophan. The derived strain C. glutamicum AROM3 produced 17 mM (3.1 g/L) l-tyrosine [29]. To broaden feedstock flexibility [30], l-tyrosine and tyramine were also produced from xylose and orange peel hydrolysate [29, 31, 32].

Here, we compared for the first time both routes for tyrosol production in the same background strain. In this study, we constructed tyrosol producing C. glutamicum strains using either 4-OH-phenylpyruvate or tyramine as precursor. With both pathways, we could successfully demonstrate the de novo production of tyrosol in recombinant C. glutamicum at g/L scale.

Results

Physiological response of C. glutamicum to tyrosol

Tyrosol can be synthesized from the amino acid l-tyrosine or from its precursor prephenate. Therefore, C. glutamicum AROM3, a genome-reduced strain, which we had previously engineered for the overproduction of l-tyrosine [29], was chosen as basis.

To evaluate the suitability of C. glutamicum AROM3 for tyrosol production, possible toxic effects of tyrosol and its potential degradation were tested. AROM3 was cultivated in the BioLector microcultivation system in CGXII minimal medium with 40 g/L glucose in the presence of 0–65 mM tyrosol for 72 h. Supplementation of tyrosol decreased the specific growth rate and biomass formation for all tested concentrations (Fig. 1A). With supplementation of 20 mM tyrosol (2.8 g/L), the growth rate of AROM3 was about half-maximal, and the lag phase almost doubled to 5.3 h. At 65 mM tyrosol, AROM3 was unable to grow. A Ki value of 22 mM was determined when growth rates were plotted against tyrosol concentrations (Fig. 1A). The observed toxic effect of tyrosol might be attributed to its inhibitory effect on bacterial ATP synthases [33]. It is noteworthy that AROM3 showed a considerably greater robustness to tyrosol than E. coli, which exhibited complete inhibition of growth at a tyrosol concentration of 25 mM [33].

Fig. 1
figure 1

Growth impairment of C. glutamicum AROM3 due to tyrosol supplementation (A) and tyrosol degradation test (B). AROM3 was cultivated in 1 mL CGXII minimal medium containing 40 g/L glucose, and varying tyrosol concentrations ranging from 0 to 65 mM. The backscatter was measured in a BioLector cultivation system and used to calculate the specific growth rate (green triangles), maximum Δbackscatter (grey circles), and lag phase (red diamonds) for the AROM3 cultures exposed to different tyrosol concentrations (A). The tyrosol concentration leading to a half-maximum growth rate could be estimated from the regression line to be 22 mM, as indicated by the green dotted line. Tyrosol concentrations determined at the beginning and the end of cultivation in the cultures containing 20 mM tyrosol were not significantly different (n.s.: p > 0.05) according to calculation with a two-sided Student’s t test (B). Values and error bars represent means and standard deviations of triplicate cultivations

In addition to the assessment of its toxic effects, tyrosol was quantified at the beginning and after 72 h of cultivation to test for its potential degradation by AROM3. The observation that the tyrosol concentrations did not decrease significantly during cultivation (Fig. 1B) indicated that tyrosol is not degraded by AROM3. Taken together, C. glutamicum AROM3 is suited for production of tyrosol to concentrations in the g/L scale.

Production of tyrosol from 4-OH-phenylpyruvate

One option to synthesize tyrosol is via 4-OH-phenylpyruvate as a precursor. This metabolite is an intermediate in l-tyrosine synthesis in many microorganisms, including E. coli [34], but not in C. glutamicum. C. glutamicum lacks a prephenate dehydrogenase (PDH, EC 1.3.1.12) for the synthesis of 4-OH-phenylpyruvate from prephenate and produces l-tyrosine via l-arogenate (pretyrosine) as an intermediate instead [35] (Fig. 2A). Therefore, we selected the gene encoding a feedback-resistant mutant of the bifunctional chorismate mutase/prephenate dehydrogenase from E. coli (TyrAEcfbr) [36, 37] for expression in C. glutamicum AROM3. As TyrAEcfbr converts chorismate via prephenate to 4-OH-phenylpyruvate, functional expression in C. glutamicum AROM3 was tested by deletion of the native chorismate mutase gene csm. l-Tyrosine auxotrophy of this deletion strain AROM3 Δcsm, was successfully overcome by expression of tyrAEcfbr (Figure S1).

Fig. 2
figure 2

Tyrosol production with plasmid-based expression of tyrAEcfbr and ARO10Sc in strain C. glutamicum AROM3 and derived deletion strains. A Tyrosol synthesis pathway with 4-OH-phenylpyruvate as intermediate via the overexpression of the heterologous genes tyrAEcfbr and ARO10Sc (green), encoding a feedback resistant mutant of the bifunctional chorismate mutase/prephenate dehydrogenase from E. coli and phenylpyruvate decarboxylase from S. cerevisiae, respectively. Gene deletions of qsuB and dapC, encoding 3-dehydroshikimate dehydratase and N-succinyl-aminooxopimelate aminotransferase, respectively, are indicated by red crosses. Final production titers of PCA, l-tyrosine, and tyrosol are shown for the tested strains (indicated by B–D). Native enzymes (black) are encoded by tyrA: l-arogenate decarboxylase, adh: alcohol dehydrogenase. PCA: protocatechuate; l-Glu: l-glutamate; 2-OG: 2-oxoglutarate; 4-OH: 4-hydroxy. NAD(P): nicotinamide adenine dinucleotide (phosphate). B–D Growth (CDW) and production of PCA, l-tyrosine, and tyrosol for C. glutamicum AROM3 (tyrAEcfbr)(ARO10Sc) (after 96 h, glucose was exhausted) (B), and its comparison to the respective dapC deletion strain (for which the glucose was exhausted after 144 h) (C), and further comparison to strain C. glutamicum AROM3 ΔdapC ΔqsuABD (tyrAEcfbr)(ARO10Sc) (which had depleted glucose after 72 h) (D). Values and error bars represent means and standard deviations of triplicate shake flask cultivations

The synthesis of tyrosol from 4-OH-phenylpyruvate has for instance been described in the yeast Saccharomyces cerevisiae [16]. In the Ehrlich pathway, Aro10Sc decarboxylates 4-OH-phenylpyruvate to 4-OH-phenylacetaldehyde [38]. The 2-oxoisovalerate decarboxylase KivD from Lactococcus lactis also showed activity for 4-OH-phenylpyruvate decarboxylation, however, in tyrosol production experiments with E. coli, Aro10 from S. cerevisiae was shown to be the better candidate [39]. Consequently, plasmid-based expression of the gene ARO10Sc, which was codon harmonized for C. glutamicum, was tested together with the expression of tyrAEcfbr. It was anticipated that 4-OH-phenylacetaldehyde, which is formed by the combined action of TyrAEcfbr and Aro10Sc, is reduced to tyrosol by (a) native alcohol dehydrogenase(s) of C. glutamicum.

Upon shake flask cultivation in CGXII medium with 40 g/L glucose, AROM3 (tyrAEcfbr) (ARO10Sc) produced 8.8 ± 0.3 mM tyrosol (equivalent to 1.21 ± 0.04 g/L) within 168 h (Fig. 2B), which was quantified by HPLC measurement and additionally verified by GC–MS analysis (Figure S2). Tyrosol was not detected in the supernatants of the parental strain AROM3 nor in the empty vector harboring strain AROM3 (tyrAEcfbr) (EV2), which both accumulated l-tyrosine (Figure S3).

The competing product l-tyrosine was also accumulated by AROM3 (tyrAEcfbr) (ARO10Sc). We previously demonstrated that deletion of the aminotransferase gene dapC in C. glutamicum wild type causes l-tyrosine bradytrophy and, thus, its involvement in the transamination of prephenate to l-arogenate in l-tyrosine biosynthesis [29]. Consequently, to lower l-tyrosine synthesis and reduce competition for the precursor prephenate, we deleted dapC in AROM3. Indeed, the l-tyrosine titer was decreased from 5.9 ± 0.2 mM for the parental strain to less than 0.3 mM (144 h) for strain AROM3 ΔdapC (tyrAEcfbr) (ARO10Sc). However, tyrosol synthesis was not increased (Fig. 2C). Even with supplementation of l-tyrosine and l-lysine to boost growth of the bradytrophic dapC deletion strain, tyrosol production remained inferior to the parental strain (Figure S4B, C). Instead of increased tyrosol titers, the strain showed an accelerated production of a different metabolite derived from the shikimate pathway, which was identified to be protocatechuate (PCA) (3,4‐dihydroxybenzoate). Due to the deletion of pcaHG, encoding the protocatechuate 3,4-dioxygenase, PCA cannot be degraded by AROM3 [40]. The PCA titer was increased by about 8 mM to a final titer of 10.3 ± 0.6 mM after 144 h cultivation upon dapC gene deletion (Fig. 2C). The accumulated PCA is not expected to have toxic effects, as growth of C. glutamicum was demonstrated for concentrations up to 500 mM PCA [41], but this by-product formation may decrease tyrosol production and is aimed to be reduced.

In C. glutamicum, PCA is synthesized from the precursor of shikimate, 3-dehydroshikimate, by 3-dehydroshikimate dehydratase encoded by qsuB (Fig. 2A). The qsuB gene is part of an operon with qsuA, qsuC and qsuD. The shikimate dehydrogenase encoded by qsuD further acts counterproductive to tyrosol synthesis, as it converts shikimate back to its precursor dehydroshikimate. Meanwhile, the expression of qsuC, encoding 3-dehydroquinate dehydratase, supports the flux towards shikimate [42]. The transcription of the qsuABCD operon is activated by QsuR in a chorismate-dependent manner [43]. It was shown that deleting qsuABD while enhancing the expression of qsuCqsuABCD::Ptuf-qsuC) increased the flux from 3-dehydroquinate towards shikimate [44], thereby benefiting the production of shikimate-derived metabolites. We, therefore, performed the chromosomal exchange (ΔqsuABCD::Ptuf-qsuC, abbreviated here to ΔqsuABD) and measured the production of aromatic compounds by the resulting strain AROM3 ΔdapC ΔqsuABD (tyrAEcfbr) (ARO10Sc). The gene deletion of qsuABD successfully reduced PCA formation to less than 0.3 mM (Fig. 2D), but tyrosol accumulation did not increase. Supplementation of l-tyrosine and l-lysine did not increase final tyrosol titers (Fig. S4D). Thus, while tyrosol production without concomitant PCA and l-tyrosine accumulation was achieved (a benefit for downstream processing), the carbon flux could not fully be rerouted to tyrosol production.

Native synthesis of 4-OH-phenylpyruvate via transamination

We expected that the bifunctional chorismate mutase/prephenate dehydrogenase from E. coli encoded by tyrAEcfbr was necessary to synthesize 4-OH-phenylpyruvate as a precursor for tyrosol synthesis via Aro10Sc. However, the observation that tyrosol production decreased together with the l-tyrosine synthesis upon deletion of dapC prompted us to consider the involvement of l-tyrosine in the tyrosol production pathway. If l-tyrosine were a precursor of 4-OH-phenylpyruvate, an involvement of TyrAEcfbr would not be required. Therefore, we compared tyrosol production of AROM3 (ARO10Sc)(tyrAEcfbr) to the respective empty vector carrying strain AROM3 (ARO10Sc)(EV1).

Surprisingly, the strain expressing only ARO10Sc produced as much tyrosol as the strain expressing ARO10Sc in combination with tyrAEcfbr (Fig. 3A), indicating that tyrAEcfbr was not required for tyrosol production. Tyrosol production was thus enabled solely by expression of ARO10Sc. In a follow-up experiment, AROM3 (ARO10Sc) without a second plasmid produced 9.4 ± 1.1 mM (1.30 ± 0.15 g/L) (Fig. 3B), while no tyrosol was detected for the respective control strain AROM3 (EV2). This corroborated that ARO10Sc is required and sufficient to enable tyrosol production by AROM3.

Fig. 3
figure 3

Tyrosol production via expression of ARO10Sc in AROM3. Growth (CDW) and production of l-tyrosine and tyrosol for C. glutamicum AROM3 (ARO10Sc)(tyrAEcfbr) compared to the respective empty vector control strain (A) (glucose was depleted after 120 h). C. glutamicum AROM3 with the single plasmid pECXT-Psyn-ARO10Sc (which exhausted the glucose after 72 h) is compared to its empty vector control strain (which depleted the glucose after 48 h) (B). Values and error bars represent means and standard deviations of triplicate shake flask cultivations

Following this unexpected observation, the metabolic source of the precursor of tyrosol production in C. glutamicum AROM3 (ARO10Sc) was sought. As expression of the prephenate dehydrogenase gene from E. coli was not required and C. glutamicum lacks a prephenate dehydrogenase, conversion of l-tyrosine to 4-OH-phenylpyruvate by transamination was regarded (Fig. 4A). To test if AROM3 (ARO10Sc) is able to produce tyrosol from l-tyrosine, we measured conversion of externally added l-tyrosine (3 mM) by permeabilized cells. Transamination of l-tyrosine requires a 2-oxo carboxylic acid, e.g., 2-oxoglutarate, as amine acceptor. Therefore, the test was conducted with and without additional supplementation of the amine acceptors pyruvate or 2-oxoglutarate (Fig. 4B). Tyrosol concentrations with supplementation of either pyruvate, 2-oxoglutarate or l-tyrosine alone hardly differed from the negative control without supplements (all < 0.3 mM). When l-tyrosine was supplemented in addition to pyruvate, 0.6 mM tyrosol accumulated, and 2.2 mM l-tyrosine remained. In contrast, the combined addition of 2-oxoglutarate and l-tyrosine resulted in a titer of 2.2 mM tyrosol with no detectable residual l-tyrosine. As expected for 2-oxoglutarate-dependent aminotransferase reactions, additional l-glutamate was formed in this set up (about + 3 mM). Taken together, native aminotransferases of C. glutamicum depending on 2-oxoglutarate (and to a lesser extent pyruvate) appear to accept l-tyrosine for transamination to 4-OH-phenylpyruvate, which subsequently is converted to tyrosol.

Fig. 4
figure 4

Tyrosol production with native 4-OH-phenylpyruvate synthesis by strain AROM3 (ARO10Sc). A Tyrosol synthesis pathway with 4-OH-phenylpyruvate as intermediate, synthesized via prephenate dehydrogenase from E. coli (heterologously expressed by tyrAEcfbr) or via native aminotransferases (encoded by undefined genes at and putative dapC) from l-tyrosine. B Conversion of l-tyrosine to tyrosol by C. glutamicum AROM3 (ARO10Sc) in a whole-cell enzyme assay with permeabilized cells upon supplementation of 3 mM l-tyrosine (l-Tyr) and surplus addition of amino acceptors pyruvate (Pyr) or 2-oxoglutarate (2-OG), as indicated. C Influence of plasmid-based overexpression of dapC on growth (CDW) and production of l-tyrosine and tyrosol by strain C. glutamicum AROM3 (ARO10Sc). Glucose was depleted after 72 h by the empty vector strain AROM3 (ARO10Sc)(EV3) and after 120 h by AROM3 (ARO10Sc)(dapC). Values and error bars represent means and standard deviations of triplicate cultivations

As the addition of 2-oxoglutarate and 3 mM l-tyrosine cocomitantly increased l-glutamate accumulation by 3 mM, we inferred that 3 mM 4-OH-phenylpyruvate were formed, but observed that only 2.2 mM tyrosol was produced. Thus, since neither 4-OH-phenylpyruvate nor 4-OH-phenylacetaldehyde were detected, about 1/3 mol/mol of 4-OH-phenylpyruvate did not contribute to tyrosol formation, but was lost. To test whether 4-OH-phenylpyruvate is unstable, 5 mM 4-OH-phenylpyruvate were incubated in sterile CGXII minimal medium under standard cultivation conditions (30 °C, 120 rpm). Almost no 4-OH-phenylpyruvate was detectable after 24 h, but instead mainly 4-formylphenol was formed among other compounds (Figure S5).

As a cross-check, we investigated growth of the l-arogenate dehydrogenase deficient deletion mutant C. glutamicum ΔtyrA. In contrast to E. coli, the tyrA gene from C. glutamicum encodes a dehydrogenase that is specific for l-arogenate but does not accept prephenate [35], a trait shared among Actinobacteria [45]. As anticipated, this strain showed l-tyrosine auxotrophy (Figure S6). Transforming this strain with pVWEx4-tyrAEcfbr for expression of the bifunctional chorismate mutase/prephenate dehydrogenase from E. coli restored growth in minimal medium (Figure S6).This indicates that, for one, C. glutamicum does not possess a prephenate dehydrogenase itself and, secondly, that 4-OH-phenylpyruvate produced by E. coli’s TyrA is converted to l-tyrosine by the native aminotransferases of C. glutamicum.

In l-lysine biosynthesis, DapC accepts N-succinyl-2-amino-6-oxopimelate as 2-oxo acid substrate and genetic evidence indicated it is one of the aminotransferases converting the 2-oxo acid prephenate to l-arogenate [29]. However, it is unknown whether DapC may also convert l-tyrosine to the 2-oxo acid 4-OH-phenylpyruvate. To test if dapC overexpression provides more 4-OH-phenylpyruvate from l-tyrosine as substrate for Aro10Sc (Fig. 4A), we constructed strain AROM3 (ARO10Sc)(dapC). However, the overexpression of dapC did not increase tyrosol production as compared to the parental strain (Fig. 4C).

Regarding the last step in tyrosol synthesis: potential alcohol dehydrogenases

It is not known which native alcohol dehydrogenase(s) reduce(s) 4-OH-phenylacetaldehyde to tyrosol in C. glutamicum. Studies conducted in E. coli showed that tyrosol production benefits from overexpressing 4-OH-phenylacetaldehyde-accepting alcohol dehydrogenases, such as YahK from E. coli [46] or ADH6 from S. cerevisiae [39]. We conducted a protein–protein BLAST search [47] for the respective protein sequences (YahkEc UniProt: P75691; ADH6Sc UniProt: Q04894) against the proteins encoded in the genome of C. glutamicum (Table S1). The search revealed that the protein with the highest amino acid sequence similarity to both alcohol dehydrogenases (with 46% identity to YahK and 37.5% identity to ADH6) is the furfural dehydrogenase FudC, encoded by cg0400 (also known as NCgl0324 or Cgl0331). FudC does not only reduce the heterocyclic aromatic aldehyde furfural [48], but also showed reductase activity with aromatic benzaldehydes in vivo, such as 4-formylphenol, protocatechuic aldehyde, and vanillin [49]. To assess the involvement of FudC in tyrosol synthesis, we deleted fudC in AROM3 and compared tyrosol production. Indeed, the synthesis of tyrosol was reduced by 75% upon deletion of the fudC gene (Fig. 5A). Moreover, 4-OH-phenylacetaldehyde was detected by GC–MS analysis exclusively in the supernatants of the fudC deletion strain. The residual production of tyrosol (2.2 ± 0.3 mM) by AROM3 ΔfudC indicated that at least one further alcohol dehydrogenase is involved in the reduction of 4-OH-phenylacetaldehyde to tyrosol. Apparently, the substrate scope of FudC is not limited to furan-ring aldehydes and benzaldehydes, but also encompasses phenylacetaldehydes.

Fig. 5
figure 5

Involvement of the furfural dehydrogenase FudC in tyrosol synthesis. Growth (CDW) and production of l-tyrosine and tyrosol by C. glutamicum AROM3 (tyrAEcfbr)(ARO10Sc) (which depleted all glucose after 96 h) compared to its respective fudC-deletion strain (here, glucose was depleted after 168 h) (A) and comparison of fudC overexpression in AROM3 (ARO10Sc)(fudC) to its respective empty vector control strain (B). Both strains had consumed all glucose after 120 h. Values and error bars represent means and standard deviations of triplicate shake flask cultivations

Next, we tested overexpression of fudC in AROM3 (ARO10Sc), but this approach did not enhance tyrosol synthesis (Fig. 5B). In line with the finding that 4-OH-phenylacetaldehyde is absent from supernatants with intact fudC, the reduction of 4-OH-phenylacetaldehyde appeared not to be a rate-limiting step.

Production of tyrosol via tyramine

During the synthesis of tyrosol from l-tyrosine via 4-OH-phenylpyruvate as intermediate, 1/3 mol/mol is lost presumably due to the instability of 4-OH-phenylpyruvate. However, there is an alternative pathway from l-tyrosine towards 4-OH-phenylacetaldehyde using an interchanged order of deamination and decarboxylation. Thereby, tyramine is formed as an intermediate instead of the unstable 4-OH-phenylpyruvate in the ARO10Sc pathway. Previously, we demonstrated that tyramine is stable under cultivation conditions and is not degraded by AROM3 [32]. To this end, we used a tyramine producing strain obtained by metabolic engineering of C. glutamicum AROM3 expressing the l-tyrosine decarboxylase gene from Levilactobacillus brevis (tdcLb) [32]. Tyramine can be oxidized to 4-OH-phenylacetaldehyde, e.g., by the tyramine oxidase Tyo from Micrococcus luteus (EC 1.4.3.4), as shown for tyrosol production by E. coli [15]. Subsequently, 4-OH-phenylacetaldehyde is reduced to tyrosol by an alcohol dehydrogenase. In this study, we used a homolog of the tyramine oxidase from Kocuria rhizophila (with 93% amino acid sequence identity to TyoMl) for the first step and opted on native alcohol dehydrogenases (Adh), including FudC for the second step (Fig. 6A). Upon cultivation of the constructed strain AROM3 (tdcLb)(tyoKr), 13.5 ± 1.1 mM tyrosol (equivalent to 1.87 ± 0.15 g/L, Fig. 6B) was produced, while no tyrosol was detected for the respective empty vector control AROM3 (tdcLb)(EV1) (Figure S7). Besides tyrosol, also l-tyrosine was present in the supernatants, but tyramine was not detected. Concluding, the expression of tyoKr in the tyramine overproducing strain is a successful strategy to produce tyrosol, yet the decarboxylation of l-tyrosine to tyramine by TdcLb seems to be the bottleneck of tyrosol production by this strain.

Fig. 6
figure 6

Tyrosol production via plasmid-based expression of tyoKr in strain AROM3 (tdcLb) and combination with ARO10Sc. A Tyrosol synthesis pathway with tyramine as intermediate, including the overexpression of the heterologous genes tdcLb and tyoKr (green), encoding l-tyrosine decarboxylase from L. brevis and tyramine oxidase from K. rhizophila, respectively, overexpression of ARO10Sc and the involvement of the furfural dehydrogenase encoded by fudC (among other alcohol dehydrogenases). B, C Comparison of growth (CDW) and production of l-tyrosine, tyramine, and tyrosol for C. glutamicum AROM3 (tdcLb)(tyoKr) (B) (glucose was exhausted after 48 h) and for the strain with additional overexpression of ARO10Sc (C) (glucose was depleted after 72 h). Values and error bars represent means and standard deviations of triplicate shake flask cultivations

As for both strains, AROM3 (ARO10Sc) and AROM3 (tdcLb)(tyoKr), the intermediate l-tyrosine accumulated, the combination of both pathways was sought. Therefore, the codon harmonized ARO10Sc gene was cloned into the plasmid pVWEx4-tyoKr and the constructed strain AROM3 (tdcLb)(ARO10Sc-tyoKr) harbored both pathways. However, this strain produced less tyrosol and more l-tyrosine remained as compared to AROM3 (tdcLb)(tyoKr) (Fig. 6C).

As the single plasmid carrying strain AROM3 (tdcLb) decarboxylated all produced l-tyrosine to tyramine (Fig. 7B), reduced expression of tdcLb in AROM3 (tdcLb)(tyoKr) as cause of the second plasmid was considered. Since division of labor is a powerful tool to reduce metabolic burden [50], AROM3 strains carrying the single plasmids with either tdcLb or tyoKr were grown in mono- or co-culture (with 50% initial CDW of both strains) (Fig. 7). This approach revealed an increase in tyrosol titer to 14.1 ± 0.3 mM (1.95 ± 0.04 g/L) and a decrease in remaining l-tyrosine to less than 0.2 mM. The results indicate that decarboxylation of l-tyrosine by plasmid-based expression of the tyramine decarboxylase gene tdcLb is more effective in the single plasmid carrying strain, overall demonstrating the potential of this measure.

Fig. 7
figure 7

Division of labor for tyrosol production via co-cultivation of AROM3 strains expressing either tdcLb or tyoKr. A Principle of tyrosol production by AROM3 carrying two plasmids (left) against labor division with single plasmid carrying AROM3 strains (right). B, C Comparison of growth (CDW) and production of l-tyrosine, tyramine, and tyrosol for AROM3 (tdcLb) and AROM3 (tyoKr) in monoculture each (B) and both strains in co-culture with 50%-CDW inoculation (C). Glucose was depleted after 48 h for all cultivations. Values and error bars represent means and standard deviations of triplicate shake flask cultivations

All in all, the highest production titers of about 14 mM tyrosol were achieved via the tyramine pathway by expression of tdcLb and tyoKr, thus clearly outperforming the pathway via 4-OH-phenylpyruvate applied in AROM3 (ARO10Sc). Not only the final titer was increased by 44%, but the production was also faster, leading to a more than doubled maximal volumetric productivity (Table 1). In addition, l-tyrosine concentrations have been substantially diminished, thereby facilitating downstream processing.

Table 1 Comparison of production parameters regarding the two pathways with either expression of ARO10Sc or tdcLb and tyoKr

Discussion

In this study, tyrosol production via expression of the gene ARO10Sc encoding the phenylpyruvate decarboxylase was shown to proceed via synthesis of 4-OH-phenylpyruvate from l-tyrosine by native aminotransferases in C. glutamicum. This pathway was more efficient for tyrosol production than the pathway involving the heterologous prephenate dehydrogenase TyrAEcfbr from E. coli. As 4-OH-phenylpyruvate is not part of the native l-tyrosine synthesis pathway of C. glutamicum, which lacks prephenate dehydrogenase activity [35], the transamination of 4-OH-phenylpyruvate and l-tyrosine does not seem to be beneficial for growth of C. glutamicum, but may be relevant for degrading l-tyrosine. Interestingly, C. glutamicum has been described to utilize l-tyrosine as sole nitrogen source, but not as sole carbon source [51]; however, the mechanism remained unclear. Here, we have shown that l-tyrosine was not converted as sole carbon source unless 2-oxoglutarate was added and formation of l-glutamate was demonstrated (Fig. 4B). Aminotransferases generally show a broad substrate spectrum. The branched-chain aminotransferase IlvE and the aromatic aminotransferase AroT accept 4-OH-phenylpyruvate as substrate and l-glutamate as amino donor, albeit with lower activities (namely, 8.8 and 2.4 µmol/min/mgprotein, respectively) compared to phenylpyruvate (13.6 and 10.7 µmol/min/mgprotein, respectively) [52]. Although l-glutamate is the preferred amino donor of AroT, the enzyme exhibits 60% of its activity also with the amino donor l-alanine. In our experiments, only 20% of the l-tyrosine was converted with addition of pyruvate as amino acceptor, indicating the (additional) involvement of aminotransferases other than AroT. Genetic evidence revealed that aminotransferase DapC (part of l-lysine biosynthesis in C. glutamicum) is active with prephenate and l-arogenate [29]. A BLAST search with yeast aminotransferase Aro8Sc, which is known to catalyze the transamination of 4-OH-phenylpyruvate to l-tyrosine [53], against the proteins encoded by the C. glutamicum genome showed the highest score to an uncharacterized aminotransferase encoded by cg0931 (NCgl0780). Thus, transamination of l-tyrosine to 4-OH-phenylpyruvate likely involves several aminotransferases in C. glutamicum.

Considering that supplemented l-tyrosine was converted to tyrosol, the strain demonstrated to be suitable for whole-cell biotransformation, a commonly used approach for the synthesis of bioactive compounds. In E. coli, three aminotransferases, TyrB, AspC, and IlvE, catalyze the transamination of 4-OH-phenylpyruvate to l-tyrosine as part of its biosynthesis pathway [54]. E. coli overexpressing ARO10Sc showed a yield on l-tyrosine of 0.45 mol/mol [23]. Notably, with a yield on l-tyrosine of 0.67 mol/mol (Fig. 4B), the here tested C. glutamicum strain overexpressing ARO10Sc outcompeted E. coli. Additional overexpression of the aminotransferase gene ARO8Sc improved yields on l-tyrosine to 0.87 mol/mol in E. coli [23], which may improve C. glutamicum-based biotransformation of l-tyrosine to tyrosol, as well.

Compared to whole-cell biotransformation, the de novo production of tyrosol is a more feasible approach due to the utilization of simple carbon and nitrogen sources (glucose and ammonia), instead of l-tyrosine and 2-oxoglutarate. The g/L scale fermentative production by AROM3 (ARO10Sc) shown here may be further improved regarding the transamination reaction, since some l-tyrosine remained at the end of cultivation. Overexpression of the responsible aminotransferase genes might help attaining the thermodynamic equilibrium of the reversible reaction faster; however, it would not alter the equilibrium itself [55]. To improve conversion towards 4-OH-phenylpyruvate, the concentrations of substrates need to be increased or that of the products decreased. The aminotransferase reaction was not hindered by accumulation of its product, 4-OH-phenylpyruvate, which was not detectable (< 0.1 mM) at any measurement timepoint. On the substrate side, however, increasing the intracellular concentration of l-tyrosine by transport engineering might be suitable to push l-tyrosine deamination. To increase the reuptake of excreted l-tyrosine, the genes encoding l-tyrosine import systems, namely, aromatic amino acid importer AroP [56] and/or the l-tyrosine permease TyrP [57], might be overexpressed. Regarding the co-substrate 2-oxoglutarate and the co-product l-glutamate, E. coli or S. cerevisiae synthesize significantly more 2-oxoglutarate than l-glutamate, whereas C. glutamicum is known for its high l-glutamate to 2-oxoglutarate ratio [58]. This is beneficial for l-tyrosine synthesis, but not for its deamination to 4-OH-phenylpyruvate. To change this ratio, the reductive amination of 2-oxoglutarate to l-glutamate can be decreased by deleting the l-glutamate dehydrogenase (Gdh) gene. The resulting strain would have a growth benefit, if it regained l-glutamate in the transamination reaction with l-tyrosine. The benefit of gdh deletion to enforce transamination reactions has been demonstrated for the production of glutarate [59].

Tyrosol production via Aro10Sc may suffer from the instability of the intermediate 4-OH-phenylpyruvate. The observed chemical conversion of 4-OH-phenylpyruvate to 4-formylphenol among other compounds under sterile conditions (Figure S5) is consistent with the observation reported by Doy [60] that the 2-oxo acid 4-OH-phenylpyruvate spontaneously converts in several steps to the aldehyde 4-formylphenol. This degradation product is known to be catabolized by C. glutamicum [49, 61]. Spontaneous degradation of 4-OH-phenylpyruvate and subsequent catabolic conversion may explain that in the whole-cell biotransformation experiment with AROM3 (ARO10Sc) about 1/3 mol/mol was lost during synthesis of tyrosol from l-tyrosine. Besides chemical instability, enzymatic degradation of 4-OH-phenylpyruvate may be possible, but has not yet been described for C. glutamicum. However, different phenylpropanoids, such as the structurally similar compound 4-OH-phenylpropionic acid, are degraded by C. glutamicum via enzymes encoded in the phd cluster [62]. Nevertheless, chemical instability of 4-OH-phenylpyruvate necessitates its fast decarboxylation at low substrate concentrations. In this respect, phenylpyruvate decarboxylase Aro10Sc that has a lower KM value for indole-3-pyruvate (0.03 mM) than for 4-OH-phenylpyruvate (0.09 mM) [38] was improved by single amino acid exchanges (Aro10ScQ448W, [38]; Aro10ScD331C, [63]). Enzyme engineering of Aro10Sc may increase its affinity to 4-OH-phenylpyruvate and thus help to overcome instability issues.

The parallel approach of tyrosol production involves the stable intermediate tyramine instead of 4-OH-phenylpyruvate via, first, decarboxylation of l-tyrosine by TdcLb and, second, deamination to 4-OH-acetaldehyde by TyoKr. Like in the Aro10-utilizing pathway, the irreversible decarboxylation with release of CO2 is a strong metabolic driving force [64]. The metabolic pull effect by Tdc explains why about 43 mol-% more tyramine was produced than l-tyrosine by the empty vector control strain [32]. Contrary to the Aro10 pathway, which initially encompasses a reversible transamination, the tyramine oxidase Tyo may exert a second beneficial pull with release of ammonia. The combination of the aforementioned factors; the pull by deamination rather than reversible transamination and the stability of the intermediate tyramine in contrast to 4-OH-phenylpyruvate, may explain the higher production titers that were achieved.

Potential disadvantages of the Tdc–Tyo pathway in comparison with the Aro10 pathway is the metabolic cost of l-glutamate, which might impose a challenge for low l-glutamate producing organisms, such as E. coli and S. cerevisiae, but less so for C. glutamicum [58]. Furthermore, the oxidative deamination catalyzed by Tyo generates hydrogen peroxide (H2O2) [65]. Given that E. coli is severely damaged by intracellular H2O2 concentrations of as little as 1 µM [66], the tyrosol synthesis route via Tyo might present a significant challenge to this bacterium. By contrast, C. glutamicum is known for its resistance towards externally added H2O2, which is about 10 times higher than that of E. coli [67]. The catalase of C. glutamicum is even marketed because of its high effectiveness (CAS Number 9001–05-2). Concluding, C. glutamicum’s distinctive characteristics, including high l-glutamate levels and high H2O2 resistance, favor the Tdc–Tyo pathway. Moreover, as C. glutamicum synthesizes l-tyrosine via l-arogenate in place of 4-OH-phenylpyruvate, unlike E. coli or S. cerevisiae, the here shown de novo production of tyrosol is unique due to its exclusion of 4-OH-phenylpyruvate as intermediate.

To reduce the metabolic burden on AROM3 (tdcLb)(tyoKr), division of labor was successfully demonstrated for tyrosol production. In contrast to inter-species consortia, for which incompatible growth requirements are common limitations [68], the consortium implemented in this study benefited from the fact that both strains belong to the same species and differ only by the last reaction step of product formation. The uniform requirements for medium and cultivation conditions, as well as similar growth behavior reduce the risk of one strain outgrowing the other, making engineered interdependencies of the strains superfluous [50]. Nevertheless, long-term stability of the co-cultivation process may be ensured through engineering interdependencies or different substrate utilization abilities, e.g., for xylose by one and arabinose by the other strain. This approach would enable the control of the strain ratio by modulation of the substrate supply [50]. As the accumulation of the intermediates l-tyrosine and tyramine was reduced compared to the mono-culture of AROM3 (tdcLb)(tyoKr), this suggests C. glutamicum efficiently transports l-tyrosine, tyramine, and tyrosol.

Taken together, the expression of the genes tdcLb and tyoKr in the engineered l-tyrosine producer C. glutamicum AROM3 for de novo production of tyrosol is very effective, especially when implemented as a co-culture with single heterologous gene expression.

Conclusion

We established de novo production of tyrosol from simple carbon and nitrogen sources via two alternative routes. Investigating tyrosol production by heterologous expression of ARO10Sc, which encodes a phenylpyruvate decarboxylase, we demonstrated the involvement of native aminotransferases in the synthesis of 4-OH-phenylpyruvate from l-tyrosine. This finding contributes to a new understanding of l-tyrosine degradation and opens new considerations for the production of l-tyrosine and its derived products. Nevertheless, due to the equilibrium of the transamination reaction and instability of the intermediate 4-OH-phenylpyruvate, we discovered that the alternative route utilizing tyramine as intermediate was superior. The production of tyrosol via heterologous expression of l-tyrosine decarboxylase and tyramine oxidase genes tdcLb and tyoKr finally resulted in titers of about 14 mM (2 g/L).

Materials and methods

Bacterial strains and cultivation conditions

Bacterial strains and plasmids used in this study are listed in Tables 2 and 3, respectively. E. coli DH5α was used as a host for plasmid construction and was grown in lysogeny broth (LB) [69] medium in 100 mL unbaffled flasks at 180 rpm at 37 °C. For better comparability of the different strains, overnight cultures of C. glutamicum were prepared with LB medium supplemented with 10 g/L glucose, to increase biomass formation especially for slowly growing strains, and cultivated at 120 rpm and 30 °C. For growth and production experiments, overnight cultures were harvested and used for inoculation of CGXII minimal medium [70], with 40 g/L glucose to an optical density at 600 nm (OD600) of 1. The cultivation was performed in 100 ml baffled flasks with a filling volume of 10 vol-% at 120 rpm and 30 °C in technical triplicates, if not stated otherwise. Antibiotics (25 mg/L kanamycin, and 5 mg/L tetracycline) as well as 1 mM isopropyl-β-d−1-thiogalactopyranoside (IPTG) to induce gene expression were supplemented if required. The amino acid l-phenylalanine (0.5 mM) was added for cultivation of all AROM3 derived strains. Growth was monitored by measuring the OD600 using a V-1200 spectrophotometer (VWR, Radnor, PA, USA) and biomass concentrations were calculated according to the experimentally determined correlation: cell dry weight concentration (CDW) = 0.347 × OD600 [g/L], which was similar to previously published results [71]. Glucose depletion was checked using glucose test strips (Macherey–Nagel GmbH & Co. KG, Düren, Germany).

Table 2 Bacterial strains used in this study
Table 3 Plasmids used in this study

To test for potential growth impairment by addition of tyrosol, the growth experiment was conducted in 48-well FlowerPlates (m2p-labs, Baesweiler, Germany) with a filling volume of 1 mL per well at 1,100 rpm and 30°C. Automated backscatter measurements by the BioLector microcultivation system (m2p-labs, Baesweiler, Germany) was used to follow the growth. Growth rates were calculated for time periods of 7 h (40 measuring points) and the maximal ones were determined for each cultivation. The lag phase was calculated as the delay, for which the maximal growth rate was not yet reached. Therefore, the initial measured backscatter (as measure for the biomass) was inserted into the equation for exponential growth with the equation parameters determined for the maximal specific growth.

For a biotransformation experiment, washed cells were resuspended in phosphate buffer (pH 7) to a CDW of 25 g/L and permeabilized with Triton-X-100 (0.125 vol-%) [72]. The permeabilized cells were diluted to 10 vol-% in 200 mM phosphate buffer (pH 7) containing biotin, PCA, and trace element with concentrations as in CGXII medium. 40 mM pyruvate or 2-oxoglutarate and 3 mM of l-tyrosine were supplemented as indicated. The mixtures were incubated in 24-well Duetz microcultivation plates (Kuhner Shaker GmbH, Herzogenrath, Germany) for 24 h at 30 °C and 180 rpm.

Molecular biology methods

Plasmid construction and transformation was performed as we described previously [32]. The ARO10 gene from S. cerevisiae (Genbank: NC_001136.10) was codon-harmonized for C. glutamicum (gene sequence: Table S2) [79] and chemically synthesized in the plasmid pECXT-Psyn by Twist Bioscience (South San Francisco, CA, USA). The tyrAEc, tyoKr, and fudCCg genes were amplified from genomic DNA of the originating organism. To introduce mutations for amino acid exchanges Met-53-Ile and Ala-354-Val into tyrAEc PCRs with respective primers (Table S3) were performed and the three obtained fragments were combined during Gibson cloning. Primers with overhangs were used to introduce an optimized ribosome binding site (RBS), which was calculated for each gene specifically using the SalisLab software [80], and overhangs to the respective vectors to enable cloning via Gibson assembly [81]. Chromosomal gene deletions were performed with two-step homologous recombination [70] using the suicide vector pK19mobsacB [82] as described previously [77]. Successful plasmid construction and chromosomal gene deletions were verified by PCR and sequencing using the appropriate primers (Table S3).

Quantification of aromatics by HPLC

Aromatic compounds were quantified with a high-performance liquid chromatography system (1200 series, Agilent Technologies Deutschland GmbH, Waldbronn, Germany). Samples were taken during growth experiments (and stored at -20 °C), diluted with water and centrifuged (14,000 rpm, 20 min). The supernatants were used for reversed-phase HPLC analysis.

5 µl sample were injected for detection of tyrosol, l-tyrosine, and PCA. The analytes were separated using a reversed phase pre- and main column (LiChrospher 100 RP18 (5 μm), 40 mM × 4 mM and CS-ODS 100 RP18 (5 μm), 125 mM × 4 mM, respectively, CS-Chromatographie Service GmbH, Langerwehe, Germany) and a gradient with (A) 0.1 vol-% formic acid and (B) methanol as a mobile phase at a constant flow rate of 0.8 mL/min. The gradient started with 10 vol-% B for 1 min, increased to 70 vol-% within 9 min, further increased to 100 vol-% B within 2 min and stayed there for another 2 min. Afterwards, the starting conditions of 10 vol-% were reached in 2 min and held for another 4 min. A diode array detector (DAD G1315B, 1200 series, Agilent Technologies) was used to detect tyrosol and l-tyrosine at a wavelength of 280 nm, while PCA was measured at a wavelength of 260 nm.

Tyramine and l-glutamate were measured via derivatization with ortho-phthaldialdehyde (OPA) using a reversed phase pre- and main column (LiChrospher 100 RP18 EC-5 μm, 40 mM × 4.6 mM and 125 mM × 4.6 mM, respectively, CS-Chromatographie Service GmbH, Langerwehe, Germany). A fluorescence detector with an excitation wavelength of 230 nm and an emission wavelength of 450 nm was used for detection of the fluorescent adducts due to the derivatization. The mobile phase consisted of (A) 0.25 vol‑% sodium acetate (pH 6.0) and (B) methanol and was applied with a gradient described previously [31].

Identification of aromatics by mass spectrometry

Samples were analyzed using gas chromatography–mass spectrometry (GC–MS), as described previously [31]. Briefly, ethyl acetate was used for extraction, of which 5 µL was injected at a split ratio of 20:1 for GC–MS analysis using a TraceGC gas chromatograph (Thermo Scientific, Waltham, MA, USA) and ISQ ion trap mass spectrometer (Thermo Scientific, Waltham, MA, USA). A TraceGOLD TG-5MS column (30 m × 0.25 mM, film thickness 0.25 μm, Thermo Scientific, Waltham, MA, USA) was used for separation with helium as carrier gas at a constant flow rate of 0.6 mL/min.

Data availability

All data generated or analyzed during this study are included in this published article and its supplementary information files.

References

  1. Uttara B, Singh AV, Zamboni P, Mahajan RT. Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol. 2009;7(1):65–74.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  2. Lee KM, Hur J, Lee Y, Yoon B-R, Choi SY. Protective effects of tyrosol against oxidative damage in L6 muscle cells. Food Sci Technol Res. 2018;24(5):943–7.

    Article  CAS  Google Scholar 

  3. Di Benedetto R, Varì R, Scazzocchio B, Filesi C, Santangelo C, Giovannini C, et al. Tyrosol, the major extra virgin olive oil compound, restored intracellular antioxidant defences in spite of its weak antioxidative effectiveness. Nutr Metab Cardiovasc Dis. 2007;17(7):535–45.

    Article  PubMed  Google Scholar 

  4. Samuel SM, Thirunavukkarasu M, Penumathsa SV, Paul D, Maulik N. Akt/FOXO3a/SIRT1-mediated cardioprotection by n-tyrosol against ischemic stress in rat in vivo model of myocardial infarction: switching gears toward survival and longevity. J Agric Food Chem. 2008;56(20):9692–8.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  5. Boronat A, Mateus J, Soldevila-Domenech N, Guerra M, Rodríguez-Morató J, Varon C, et al. Cardiovascular benefits of tyrosol and its endogenous conversion into hydroxytyrosol in humans. A randomized, controlled trial. Free Radic Biol Med. 2019;143:471–81.

    Article  PubMed  CAS  Google Scholar 

  6. St-Laurent-Thibault C, Arseneault M, Longpré F, Ramassamy C. Tyrosol and hydroxytyrosol, two main components of olive oil, protect N2a cells against amyloid-β-induced toxicity. Involvement of the NF-κB signaling. Curr Alzheimer Res. 2011;8(5):543–51.

    Article  PubMed  CAS  Google Scholar 

  7. Yoo S-E, inventor. Antihypertensive polyhalohydroxyisopropyl phenylalka (e) noic acid esters of alkylaminohydroxypropyloxyphenylalkyl alcohols: U.S. Patent. US4450172.

  8. Ippolito RM, Vigmond S, inventors. Process for preparing substituted phenol ethers via oxazolidine-structure intermediates: U.S. Patent. US4760182.

  9. Xu J, Su Z, Feng P. Activity of tyrosol glucosyltransferase and improved salidroside production through biotransformation of tyrosol in Rhodiola sachalinensis cell cultures. J Biotechnol. 1998;61(1):69–73.

    Article  CAS  Google Scholar 

  10. Sun S, Tuo Q, Li D, Wang X, Li X, Zhang Y, et al. Antioxidant effects of salidroside in the cardiovascular system. Evid Based Complement Alternat Med. 2020;2020:9568647.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Reiter MJ. Cardiovascular drug class specificity: beta-blockers. Prog Cardiovasc Dis. 2004;47(1):11–33.

    Article  PubMed  CAS  Google Scholar 

  12. Sysolyatin SV, Kryukov YA, Malykhin VV, Muradov KK, Chernysheva GA, Aliev OI, et al. p-Tyrosol: a new synthetic method and new types of pharmacological activity. Russ Chem Bull. 2015;64(9):2210–4.

    Article  CAS  Google Scholar 

  13. Larriba M, Omar S, Navarro P, García J, Rodríguez F, Gonzalez-Miquel M. Recovery of tyrosol from aqueous streams using hydrophobic ionic liquids: a first step towards developing sustainable processes for olive mill wastewater (OMW) management. RSC Adv. 2016;6(23):18751–62.

    Article  CAS  Google Scholar 

  14. Lucci P, Bertoz V, Pacetti D, Moret S, Conte L. Effect of the refining process on total hydroxytyrosol, tyrosol, and tocopherol contents of olive oil. Foods. 2020;9(3):292.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  15. Satoh Y, Tajima K, Munekata M, Keasling JD, Lee TS. Engineering of a tyrosol-producing pathway, utilizing simple sugar and the central metabolic tyrosine, Escherichia coli. J Agric Food Chem. 2012;60(4):979–84.

    Article  PubMed  CAS  Google Scholar 

  16. Sentheshanmuganathan S, Elsden SR. The mechanism of the formation of tyrosol by Saccharomyces cerevisiae. Biochem J. 1958;69(2):210–8.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  17. Chen H, Fink GR. Feedback control of morphogenesis in fungi by aromatic alcohols. Genes Dev. 2006;20(9):1150–61.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  18. Chen H, Fujita M, Feng Q, Clardy J, Fink GR. Tyrosol is a quorum-sensing molecule in Candida albicans. Proc Natl Acad Sci USA. 2004;101(14):5048–52.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  19. Liu H, Tian Y, Zhou Y, Kan Y, Wu T, Xiao W, et al. Multi-modular engineering of Saccharomyces cerevisiae for high-titre production of tyrosol and salidroside. Microb Biotechnol. 2021;14(6):2605–16.

    Article  PubMed  CAS  Google Scholar 

  20. Guo W, Huang Q, Feng Y, Tan T, Niu S, Hou S, et al. Rewiring central carbon metabolism for tyrosol and salidroside production in Saccharomyces cerevisiae. Biotech Bioeng. 2020;117(8):2410–9.

    Article  CAS  Google Scholar 

  21. Jiang J, Yin H, Wang S, Zhuang Y, Liu S, Liu T, et al. Metabolic engineering of Saccharomyces cerevisiae for high-level production of salidroside from glucose. J Agric Food Chem. 2018;66(17):4431–8.

    Article  PubMed  CAS  Google Scholar 

  22. Porro D, Gasser B, Fossati T, Maurer M, Branduardi P, Sauer M, et al. Production of recombinant proteins and metabolites in yeasts: when are these systems better than bacterial production systems? Appl Microbiol Biotechnol. 2011;89(4):939–48.

    Article  PubMed  CAS  Google Scholar 

  23. Xue Y, Chen X, Yang C, Chang J, Shen W, Fan Y. Engineering Eschericha coli for enhanced tyrosol production. J Agric Food Chem. 2017;65(23):4708–14.

    Article  PubMed  CAS  Google Scholar 

  24. Yang C, Chen X, Chang J, Zhang L, Xu W, Shen W, et al. Reconstruction of tyrosol synthetic pathways in Escherichia coli. Chin J Chem Eng. 2018;26(12):2615–21.

    Article  CAS  Google Scholar 

  25. Xu W, Yang C, Xia Y, Zhang L, Liu C, Yang H, et al. High-Level production of tyrosol with noninduced recombinant Escherichia coli by metabolic engineering. J Agric Food Chem. 2020;68(16):4616–23.

    Article  PubMed  CAS  Google Scholar 

  26. Lai Y, Chen H, Liu L, Fu B, Wu P, Li W, et al. Engineering a synthetic pathway for tyrosol synthesis in Escherichia coli. ACS Synth Biol. 2022;11(1):441–7.

    Article  PubMed  CAS  Google Scholar 

  27. Taguchi S, Ooi T, Mizuno K, Matsusaki H. Advances and needs for endotoxin-free production strains. Appl Microbiol Biotechnol. 2015;99(22):9349–60.

    Article  PubMed  CAS  Google Scholar 

  28. Wendisch VF. Metabolic engineering advances and prospects for amino acid production. Metab Eng. 2020;58:17–34.

    Article  PubMed  CAS  Google Scholar 

  29. Kurpejović E, Burgardt A, Bastem GM, Junker N, Wendisch VF, Sariyar AB. Metabolic engineering of Corynebacterium glutamicum for ʟ-tyrosine production from glucose and xylose. J Biotechnol. 2023;363:8–16.

    Article  PubMed  Google Scholar 

  30. Wendisch VF, Brito LF, Gil Lopez M, Hennig G, Pfeifenschneider J, Sgobba E, et al. The flexible feedstock concept in industrial biotechnology: metabolic engineering of Escherichia coli, Corynebacterium glutamicum, Pseudomonas, Bacillus and yeast strains for access to alternative carbon sources. J Biotechnol. 2016;234:139–57.

    Article  PubMed  CAS  Google Scholar 

  31. Junker N, Sariyar Akbulut B, Wendisch VF. Utilization of orange peel waste for sustainable amino acid production by Corynebacterium glutamicum. Front Bioeng Biotechnol. 2024;12:1419444.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Poethe S-S, Junker N, Meyer F, Wendisch VF. Sustainable production of the drug precursor tyramine by engineered Corynebacterium glutamicum. Appl Microbiol Biotechnol. 2024;108(1):499.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  33. Amini A, Liu M, Ahmad Z. Understanding the link between antimicrobial properties of dietary olive phenolics and bacterial ATP synthase. Int J Biol Macromol. 2017;101:153–64.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  34. Hudson GS, Wong V, Davidson BE. Chorismate mutase/prephenate dehydrogenase from Escherichia coli K12: purification, characterization, and identification of a reactive cysteine. Biochemistry. 1984;23(25):6240–9.

    Article  PubMed  CAS  Google Scholar 

  35. Fazel AM, Jensen RA. Obligatory biosynthesis of ʟ-tyrosine via the pretyrosine branchlet in coryneform bacteria. J Bacteriol. 1979;138(3):805–15.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  36. Lütke-Eversloh T, Stephanopoulos G. Feedback inhibition of chorismate mutase/prephenate dehydrogenase (TyrA) of Escherichia coli: generation and characterization of tyrosine-insensitive mutants. Appl Environ Microbiol. 2005;71(11):7224–8.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Lütke-Eversloh T, Stephanopoulos G. ʟ-tyrosine production by deregulated strains of Escherichia coli. Appl Microbiol Biotechnol. 2007;75(1):103–10.

    Article  PubMed  Google Scholar 

  38. Kneen MM, Stan R, Yep A, Tyler RP, Saehuan C, McLeish MJ. Characterization of a thiamine diphosphate-dependent phenylpyruvate decarboxylase from Saccharomyces cerevisiae. FEBS J. 2011;278(11):1842–53.

    Article  PubMed  CAS  Google Scholar 

  39. Li X, Chen Z, Wu Y, Yan Y, Sun X, Yuan Q. Establishing an artificial pathway for efficient biosynthesis of hydroxytyrosol. ACS Synth Biol. 2018;7(2):647–54.

    Article  PubMed  CAS  Google Scholar 

  40. Baumgart M, Unthan S, Kloß R, Radek A, Polen T, Tenhaef N, et al. Corynebacterium glutamicum chassis C1*: building and testing a novel platform host for synthetic biology and industrial biotechnology. ACS Synth Biol. 2018;7(1):132–44.

    Article  PubMed  CAS  Google Scholar 

  41. Kogure T, Suda M, Hiraga K, Inui M. Protocatechuate overproduction by Corynebacterium glutamicum via simultaneous engineering of native and heterologous biosynthetic pathways. Metab Eng. 2021;65:232–42.

    Article  PubMed  CAS  Google Scholar 

  42. Teramoto H, Inui M, Yukawa H. Regulation of expression of genes involved in quinate and shikimate utilization in Corynebacterium glutamicum. Appl Environ Microbiol. 2009;75(11):3461–8.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  43. Kubota T, Tanaka Y, Takemoto N, Watanabe A, Hiraga K, Inui M, et al. Chorismate-dependent transcriptional regulation of quinate/shikimate utilization genes by LysR-type transcriptional regulator QsuR in Corynebacterium glutamicum: carbon flow control at metabolic branch point. Mol Microbiol. 2014;92(2):356–68.

    Article  PubMed  CAS  Google Scholar 

  44. Syukur Purwanto H, Kang M-S, Ferrer L, Han S-S, Lee J-Y, Kim H-S, et al. Rational engineering of the shikimate and related pathways in Corynebacterium glutamicum for 4-hydroxybenzoate production. J Biotechnol. 2018;282:92–100.

    Article  PubMed  CAS  Google Scholar 

  45. Song J, Bonner CA, Wolinsky M, Jensen RA. The TyrA family of aromatic-pathway dehydrogenases in phylogenetic context. BMC Biol. 2005;3:13.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Yang H, Xue Y, Yang C, Shen W, Fan Y, Chen X. Modular engineering of tyrosol production in Escherichia coli. J Agric Food Chem. 2019;67(14):3900–8.

    Article  PubMed  CAS  Google Scholar 

  47. Johnson M, Zaretskaya I, Raytselis Y, Merezhuk Y, McGinnis S, Madden TL. NCBI BLAST: a better web interface. Nucleic Acids Res. 2008;36(Web server issue):W5-9.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  48. Tsuge Y, Kudou M, Kawaguchi H, Ishii J, Hasunuma T, Kondo A. FudC, a protein primarily responsible for furfural detoxification in Corynebacterium glutamicum. Appl Microbiol Biotechnol. 2016;100(6):2685–92.

    Article  PubMed  CAS  Google Scholar 

  49. Kim H-S, Choi J-A, Kim B-Y, Ferrer L, Choi J-M, Wendisch VF, et al. Engineered Corynebacterium glutamicum as the platform for the production of aromatic aldehydes. Front Bioeng Biotechnol. 2022;10: 880277.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Sgobba E, Wendisch VF. Synthetic microbial consortia for small molecule production. Curr Opin Biotechnol. 2020;62:72–9.

    Article  PubMed  CAS  Google Scholar 

  51. Zhao Z, Ding J-Y, Li T, Zhou N-Y, Liu S-J. The ncgl1108 (PhePCg) gene encodes a new ʟ-Phe transporter in Corynebacterium glutamicum. Appl Microbiol Biotechnol. 2011;90(6):2005–13.

    Article  PubMed  CAS  Google Scholar 

  52. Marienhagen J, Kennerknecht N, Sahm H, Eggeling L. Functional analysis of all aminotransferase proteins inferred from the genome sequence of Corynebacterium glutamicum. J Bacteriol. 2005;187(22):7639–46.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  53. Urrestarazu A, Vissers S, Iraqui I, Grenson M. Phenylalanine- and tyrosine-auxotrophic mutants of Saccharomyces cerevisiae impaired in transamination. Mol Gen Genet. 1998;257(2):230–7.

    Article  PubMed  CAS  Google Scholar 

  54. Gelfand DH, Steinberg RA. Escherichia coli mutants deficient in the aspartate and aromatic amino acid aminotransferases. J Bacteriol. 1977;130(1):429–40.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  55. Tufvesson P, Lima-Ramos J, Jensen JS, Al-Haque N, Neto W, Woodley JM. Process considerations for the asymmetric synthesis of chiral amines using transaminases. Biotech Bioeng. 2011;108(7):1479–93.

    Article  CAS  Google Scholar 

  56. Wehrmann A, Morakkabati S, Krämer R, Sahm H, Eggeling L. Functional analysis of sequences adjacent to dapE of Corynebacterium glutamicum reveals the presence of aroP, which encodes the aromatic amino acid transporter. J Bacteriol. 1995;177(20):5991–3.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  57. Yang G, Xiong S, Huang M, Liu B, Shao Y, Chen X. Metabolic engineering of Corynebacterium crenatum for enhanced ʟ-tyrosine production from mannitol and glucose. Microb Cell Fact. 2024;23(1):287.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  58. Paczia N, Nilgen A, Lehmann T, Gätgens J, Wiechert W, Noack S. Extensive exometabolome analysis reveals extended overflow metabolism in various microorganisms. Microb Cell Fact. 2012;11:122.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  59. Prell C, Busche T, Rückert C, Nolte L, Brandenbusch C, Wendisch VF. Adaptive laboratory evolution accelerated glutarate production by Corynebacterium glutamicum. Microb Cell Fact. 2021;20(1):97.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  60. Doy CH. Alkaline conversion of 4-hydroxyphenylpyruvic acid to 4-hydroxybenzaldehyde. Nature. 1960;186:529–31.

    Article  PubMed  CAS  Google Scholar 

  61. Ding W, Si M, Zhang W, Zhang Y, Chen C, Zhang L, et al. Functional characterization of a vanillin dehydrogenase in Corynebacterium glutamicum. Sci Rep. 2015;5:8044.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  62. Kallscheuer N, Vogt M, Kappelmann J, Krumbach K, Noack S, Bott M, et al. Identification of the phd gene cluster responsible for phenylpropanoid utilization in Corynebacterium glutamicum. Appl Microbiol Biotechnol. 2016;100(4):1871–81.

    Article  PubMed  CAS  Google Scholar 

  63. Xia Y, Qi L, Shi X, Chen K, Peplowski L, Chen X. Construction of an Escherichia coli cell factory for de novo synthesis of tyrosol through semi-rational design based on phenylpyruvate decarboxylase ARO10 engineering. Int J Biol Macromol. 2023;253: 127385.

    Article  PubMed  CAS  Google Scholar 

  64. Porro D, Branduardi P, Sauer M, Mattanovich D. Old obstacles and new horizons for microbial chemical production. Curr Opin Biotechnol. 2014;30:101–6.

    Article  PubMed  CAS  Google Scholar 

  65. Yagodina OV, Nikol’skaya EB, Khovanskikh AE, Kormilitsyn BN. Amine oxidases of microorganisms. J Evol Biochem Physiol. 2002;38(3):251–8.

    Article  CAS  Google Scholar 

  66. Imlay JA. Cellular defenses against superoxide and hydrogen peroxide. Annu Rev Biochem. 2008;77:755–76.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  67. Milse J, Petri K, Rückert C, Kalinowski J. Transcriptional response of Corynebacterium glutamicum ATCC 13032 to hydrogen peroxide stress and characterization of the OxyR regulon. J Biotechnol. 2014;190:40–54.

    Article  PubMed  CAS  Google Scholar 

  68. Roell GW, Zha J, Carr RR, Koffas MA, Fong SS, Tang YJ. Engineering microbial consortia by division of labor. Microb Cell Fact. 2019;18(1):35.

    Article  PubMed  PubMed Central  Google Scholar 

  69. Bertani G. Studies on lysogenesis. I. The mode of phage liberation by lysogenic Escherichia coli. J Bacteriol. 1951;62(3):293–300.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  70. Eggeling L, Bott M. Handbook of Corynebacterium glutamicum. Boca Raton: CRC Press; 2005.

    Book  Google Scholar 

  71. Kiefer P, Heinzle E, Zelder O, Wittmann C. Comparative metabolic flux analysis of lysine-producing Corynebacterium glutamicum cultured on glucose or fructose. Appl Environ Microbiol. 2004;70(1):229–39.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  72. Yuan Y, Heinzle E. Permeabilization of Corynebacterium glutamicum for NAD(P)H-dependent intracellular enzyme activity measurement. C R Chim. 2009;12(10–11):1154–62.

    Article  CAS  Google Scholar 

  73. Hanahan D. Studies on transformation of Escherichia coli with plasmids. J Mol Biol. 1983;166(4):557–80.

    Article  PubMed  CAS  Google Scholar 

  74. Henke NA, Krahn I, Wendisch VF. Improved plasmid-based inducible and constitutive gene expression in Corynebacterium glutamicum. Microorganisms. 2021;9(1):204.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  75. Eikmanns BJ, Kleinertz E, Liebl W, Sahm H. A family of Corynebacterium glutamicum/Escherichia coli shuttle vectors for cloning, controlled gene expression, and promoter probing. Gene. 1991;102(1):93–8.

    Article  PubMed  CAS  Google Scholar 

  76. Ferrer L, Mindt M, Suarez-Diez M, Jilg T, Zagorščak M, Lee J-H, et al. Fermentative indole production via bacterial tryptophan synthase alpha subunit and plant indole-3-glycerol phosphate lyase enzymes. J Agric Food Chem. 2022;70(18):5634–45.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  77. Walter T, Al Medani N, Burgardt A, Cankar K, Ferrer L, Kerbs A, et al. Fermentative N-methylanthranilate production by engineered Corynebacterium glutamicum. Microorganisms. 2020;8(6):866.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  78. Peters-Wendisch P, Schiel B, Wendisch VF, Katsoulidis E, Mockel B, Sahm H, et al. Pyruvate carboxylase is a major bottleneck for glutamate and lysine production by Corynebacterium glutamicum. J Mol Microbiol Biotechnol. 2001;3(2):295.

    PubMed  CAS  Google Scholar 

  79. Haupka C. chaupka/codon_harmonization: release v1.2.0. Zenodo; 2020.

  80. Salis HM, Mirsky EA, Voigt CA. Automated design of synthetic ribosome binding sites to control protein expression. Nat Biotechnol. 2009;27(10):946–50.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  81. Gibson DG, Young L, Chuang R-Y, Venter JC, Hutchison CA, Smith HO. Enzymatic assembly of DNA molecules up to several hundred kilobases. Nat Methods. 2009;6(5):343–5.

    Article  PubMed  CAS  Google Scholar 

  82. Schäfer A, Tauch A, Jäger W, Kalinowski J, Thierbach G, Pühler A. Small mobilizable multi-purpose cloning vectors derived from the Escherichia coli plasmids pK18 and pK19: selection of defined deletions in the chromosome of Corynebacterium glutamicum. Gene. 1994;145(1):69–73.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Dr. Jung-Won Youn (from Stuttgart University) for providing the strain C. glutamicum ΔtyrA.

Funding

Open Access funding enabled and organized by Projekt DEAL. The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. We acknowledge the financial support of the German Research Foundation (DFG) and the Open Access Publication Fund of Bielefeld University for the article processing charge. The funders had no role in the design of the study, in the collection, analyses, or interpretation of data, in the writing of the manuscript, or in the decision to publish the results.

Author information

Authors and Affiliations

Authors

Contributions

NJ and S-SP carried out experimental procedures of the present study. NJ, S-SP, and VFW analyzed data. NJ and S-SP drafted the manuscript. VFW coordinated the study. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Volker F. Wendisch.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

This paper is dedicated to Professor Dr. Michael Bott on the occasion of his 65th birthday and his significant contributions to the field of microbial biotechnology.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Junker, N., Poethe, SS. & Wendisch, V.F. Two routes for tyrosol production by metabolic engineering of Corynebacterium glutamicum. Biotechnol. Biofuels Bioprod. 18, 43 (2025). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13068-025-02641-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13068-025-02641-6

Keywords